Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

Clicks: 423
ID: 115788
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 28 articles by views in american journal of obstetrics and gynecology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
None of the registries has provided a risk estimate exceeding that expected in the disorder treated, and no pattern of defects has been observed. Whereas information from the larger registries is reassuring regarding risk, these studies cannot rule out possible small excess risks from use of these d …
Reference Key
r2000americanmonitoring Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Reiff-Eldridge R;Heffner CR;Ephross SA;Tennis PS;White AD;Andrews EB;;
Journal american journal of obstetrics and gynecology
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10649172
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine pregnancy female Prospective Studies risk factors pregnancy complications abnormalities pregnancy outcome* antiviral agents / adverse effects pregnancy trimester pmid:10649172 doi:10.1016/s0002-9378(00)70506-0 r reiff-eldridge c r heffner e b andrews drug-induced / epidemiology* acyclovir / adverse effects anticonvulsants / adverse effects drug industry* epilepsy / drug therapy lamotrigine first registries sumatriptan / adverse effects triazines / adverse effects vasoconstrictor agents / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.